BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18245089)

  • 1. Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.
    Voong LN; Slater AR; Kratovac S; Cressman DE
    J Biol Chem; 2008 Apr; 283(14):9031-9. PubMed ID: 18245089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter.
    Bewry NN; Bolick SC; Wright KL; Harton JA
    J Biol Chem; 2007 Sep; 282(36):26178-84. PubMed ID: 17623662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination.
    Morgan JE; Shanderson RL; Boyd NH; Cacan E; Greer SF
    Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26181363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nuclear export sequence in the MHC CIITA.
    Chiu E; Gold T; Fettig V; LeVasseur MT; Cressman DE
    J Immunol; 2015 Jun; 194(12):6102-11. PubMed ID: 25948812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GTP-binding domain of class II transactivator regulates its nuclear export.
    Raval A; Weissman JD; Howcroft TK; Singer DS
    J Immunol; 2003 Jan; 170(2):922-30. PubMed ID: 12517958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
    Bhat KP; Truax AD; Greer SF
    J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2.
    Kumari G; Mahalingam S
    Exp Cell Res; 2009 Oct; 315(16):2775-90. PubMed ID: 19555684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 phosphorylates HIF-2α and regulates its activity by controlling its CRM1-dependent nuclear shuttling.
    Gkotinakou IM; Befani C; Simos G; Liakos P
    J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30962349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTP binding by class II transactivator: role in nuclear import.
    Harton JA; Cressman DE; Chin KC; Der CJ; Ting JP
    Science; 1999 Aug; 285(5432):1402-5. PubMed ID: 10464099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
    Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
    J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
    Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
    J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.
    Spilianakis C; Papamatheakis J; Kretsovali A
    Mol Cell Biol; 2000 Nov; 20(22):8489-98. PubMed ID: 11046145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function.
    Sisk TJ; Nickerson K; Kwok RP; Chang CH
    Int Immunol; 2003 Oct; 15(10):1195-205. PubMed ID: 13679389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation.
    Harton JA; O'Connor W; Conti BJ; Linhoff MW; Ting JP
    Hum Immunol; 2002 Jul; 63(7):588-601. PubMed ID: 12072194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
    FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator.
    Cressman DE; O'Connor WJ; Greer SF; Zhu XS; Ting JP
    J Immunol; 2001 Oct; 167(7):3626-34. PubMed ID: 11564775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.